Intended Use

The FloPatch FP120 is indicated for use for the noninvasive assessment of blood flow in peripheral vasculature with continuous wave ultrasound mode. It is intended for use by medical professionals in hospital and professional environments on adults, prescription use only.

Technology

The device consists of an ultrasonic transducer and a signal processing unit mounted on an adhesive strap. It transmits continuous wave ultrasound to peripheral vessels, receives Doppler-shifted signals reflected by moving blood cells, and wirelessly transmits data to a mobile medical application for processing and display of flow parameters.

Performance

Performance testing verified the device meets requirements for acoustic output, ultrasound safety and performance, electrical safety, EMC, ingress protection (IP67), material and shelf life, usability, hardware, and software including flow accuracy and algorithm validation. Biocompatibility tests and simulated use cycle testing were also passed, demonstrating safety and effectiveness for its indications.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    4/11/2025

    2 months
  • 2

    FDA Approval

    6/20/2025

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.